We hypothesize that creating unique treatment algorithm
combining current therapeutic modalities such as Stellate Ganglion Blocks (SGB), Transcranial
Magnetic Stimulation (TMS) therapy, and ketamine therapy, within a consolidated timeframe,
will yield synergistic outcomes among patients presenting with comorbid post-traumatic stress
disorder (PTSD), depression, and/or anxiety.